Design of clinical trials for biomarker research in oncology.

Design of clinical trials for biomarker research in oncology.

Item
http://www.wikidata.org/entity/Q35789708
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewMast cells as a potential prognostic marker in prostate cancerNext-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneityMethods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewOptimizing Trial Designs for Targeted TherapiesA review of phase II trial designs for initial marker validation.Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.Protein and peptide biomarkers in organ transplantation.Drug transporters in breast cancer: response to anthracyclines and taxanes.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
P2860

Design of clinical trials for biomarker research in oncology.

Item
http://www.wikidata.org/entity/Q35789708
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Design of clinical trials for biomarker research in oncology.
@ast
Design of clinical trials for biomarker research in oncology.
@en
type
label
Design of clinical trials for biomarker research in oncology.
@ast
Design of clinical trials for biomarker research in oncology.
@en
prefLabel
Design of clinical trials for biomarker research in oncology.
@ast
Design of clinical trials for biomarker research in oncology.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Design of clinical trials for biomarker research in oncology.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932